Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
Open Access
- 1 November 2020
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (5), 2001875
- https://doi.org/10.1183/13993003.01875-2020
Abstract
Background: Viral respiratory infections are the main causes of asthma exacerbation. The susceptibility of patients with asthma to develop an exacerbation when they present with severe pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is unknown. The objective of this study was to investigate the characteristics and outcomes of asthmatic patients with coronavirus disease 2019 (COVID-19) pneumonia who required hospitalisation during the spring 2020 outbreak in Paris, France. Methods: A prospective cohort follow-up was carried out from 15 March to 15 April 2020 in Bicetre Hospital, University Paris-Saclay, France. All hospitalised patients with a SARS-CoV-2 infection who reported a history of asthma were included. Results: Among 768 hospitalised patients, 37 (4.8%) reported a history of asthma, which had been previously confirmed by a pulmonologist in 85% of cases. These asthmatic patients were mainly female (70%) and nonsmokers (85%), with a median age of 54 years (interquartile range (IQR) 42-67 years). None of them presented with an asthma exacerbation. 22 (59%) had major comorbidities and 31 (84%) had a body mass index >= 25 kg.m(-2). The most common comorbidities were obesity (36%), hypertension (27%) and diabetes (19%). All patients had a confirmed diagnosis of COVID-19 pneumonia on computed tomography of the chest. Eosinopenia was a typical biological feature with a median count of 0 cells.mm(-3) (IQR 0-0 cells.mm(-3)). 11 patients (30%) were admitted into the intensive care unit, with three deaths (8.1%) occurring in the context of comorbidities. Conclusion: Asthma patients were not overrepresented among those with severe pneumonia due to SARS-CoV-2 infection who required hospitalisation. The worst outcomes were observed mainly in patients with major comorbidities.This publication has 34 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Prévalence et prise en charge de l’asthme de l’adulte en France en 2018 : enquête ASTHMAPOPRevue D'epidemiologie Et de Sante Publique, 2019
- Asthma over the Adult Life CourseClinics in Chest Medicine, 2018
- The microbiology of asthmaNature Reviews Microbiology, 2012
- Overdiagnosis of asthma in obese and nonobese adultsCMAJ : Canadian Medical Association Journal, 2008
- The relationship of sex to asthma prevalence, health care utilization, and medications in a large managed care organizationAnnals of Allergy, Asthma & Immunology, 2003
- Obesity May Increase the Incidence of Asthma in Women but Not in Men: Longitudinal Observations from the Canadian National Population Health SurveysAmerican Journal of Epidemiology, 2002